Lextegrity’s Integrity Gateway Approvals & Disclosures and Transaction Monitoring applications were chosen in an ongoing DOJ and SEC FCPA investigation by a leading global biopharmaceutical company.
A leading global life sciences company sought to enhance compliance controls and processes amid an ongoing FCPA investigation. Lextegrity’s Integrity Gateway Approvals & Disclosures and Integrity Gateway Approvals & Disclosures applications were implemented quickly without the need for data scientists and engineers globally and in multiple languages. Compliance analytics and automation enhancements were implemented to bolster third-party risk management as well as monitor sponsorships and donations and benefits to government officials and healthcare professionals.
This case study will address:
The high-risk areas this leading biopharmaceutical company needed to address